Atıf Formatları
Sorafenib-induced severe urticaria in a patient with hepatocellular cancer
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

F. Y. Musri Et Al. , "Sorafenib-induced severe urticaria in a patient with hepatocellular cancer," JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.22, no.2, pp.350-353, 2016

Musri, F. Y. Et Al. 2016. Sorafenib-induced severe urticaria in a patient with hepatocellular cancer. JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.22, no.2 , 350-353.

Musri, F. Y., Mutlu, H., Salim, D. K., Eryilmaz, M. K., ÜNAL, B., Tural, D., ... COŞKUN, H. Ş.(2016). Sorafenib-induced severe urticaria in a patient with hepatocellular cancer. JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.22, no.2, 350-353.

Musri, Fatma Et Al. "Sorafenib-induced severe urticaria in a patient with hepatocellular cancer," JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.22, no.2, 350-353, 2016

Musri, Fatma Y. Et Al. "Sorafenib-induced severe urticaria in a patient with hepatocellular cancer." JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.22, no.2, pp.350-353, 2016

Musri, F. Y. Et Al. (2016) . "Sorafenib-induced severe urticaria in a patient with hepatocellular cancer." JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.22, no.2, pp.350-353.

@article{article, author={Fatma Yalcin Musri Et Al. }, title={Sorafenib-induced severe urticaria in a patient with hepatocellular cancer}, journal={JOURNAL OF ONCOLOGY PHARMACY PRACTICE}, year=2016, pages={350-353} }